Article
Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics.
Current drug metabolism - 1 Aug 2005
Lamba Jatinder, Lamba Vishal, Schuetz Erin
Abstract excerpt
The defense mechanisms responsible for protecting the body from endogenous toxins are also involved in the metabolism of drugs and are composed of phase I and phase II drug metabolizing enzymes, as well as drug transporters. Numerous drugs and chemicals have been shown to modulate the expression of the genes involved in these three drug-detoxifying processes. Induction of these genes contributes to both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
